CA ATC C02CA04 · updated 2 Nov 2026
Doxazosin shortage in Canada
Is there a Doxazosin shortage in Canada?
Yes. As of 2 Nov 2026, 2 Doxazosin products are reported short in Canada, the first since 15 Sep 2026. The company estimate for the return is 6 Nov 2026 (latest 12 Mar 2027). Main reason: manufacturing problem.
Also short in Italy, Austria, Czechia, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | JAMP-DOXAZOSIN (Bottle of 100) | JAMP PHARMA CORPORATION | 15 Sep 2026 | 12 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DOXAZOSIN (100 BTL) | APOTEX INC | 13 Oct 2026 | 6 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.